| 查看: 491 | 回复: 0 | |||
[交流]
请问慢乙肝的病人敢用苯溴马隆吗
|
|
如题，病人别嘌醇0.1 bid 后尿酸仍在五百多，现在建议苯溴马隆口服，但是查了资料说赛诺菲已经在03年因为苯溴马隆的肝损召回了，没有这方面的经验，请指教。 http://apps.who.int/medicinedocs/en/d/Js4947e/1.4.html 这是WHO的关于苯溴马隆召回的材料。 BENZ-BROMARONE - Withdrawn due to reports of liver damage France. Sanofi-Synthélabo has withdrawn its hyperuricaemic product benzbromarone (Desuric) in France following reports of serious liver damage associated with the product's use. Benzbromarone (Desuric) has been marketed in France since 1976, but rare reports of serious cytolytic liver damage, including fatal cases and others requiring liver transplants, have led to an unfavourable benefit/risk ratio. The company has therefore decided to stop the marketing of this product in France and to recall all stocks. Reference: Chaibriant H. Stop marketing of proprietary medical product DESURIC (Rm) (benzbromarone), 22 Apr 2003. Available from URL: http://agmed.sante.gouv.fr |
回复此楼» 猜你喜欢
刚查时间戳
已经有16人回复
-
德国科隆大学医学中心Prof. Vogt 研究组招聘CSC公派博士生。
已经有2人回复
-
循环系统论文润色/翻译怎么收费?
已经有194人回复
-
求欧洲（英国）的访学岗位——神经退行性疾病纳米靶向药物方向
已经有1人回复
-
复旦大学-淮安大学联培招生
已经有0人回复
-
求澳大利亚，欧洲，新加坡 神经退行性疾病纳米药物研究方向的访学职位
已经有0人回复
-
filecode有几个（（JTJC））
已经有676人回复
» 本主题相关商家推荐: (我也要在这里推广)
